| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.5M | -60.0% |
| R&D Expense | $67.1M | +17.7% |
| SG&A Expense | $20.2M | +26.2% |
| Operating Income | -$85.8M | -24.0% |
| Pre-tax Income | -$83.8M | -21.1% |
| Net Income | -$83.8M | -21.1% |
| EPS (Basic) | -$2.58 | -2.0% |
| EPS (Diluted) | -$2.58 | -2.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $38.9M | +62.1% |
| Short-term Investments | $210.1M | +26.9% |
| Current Assets | $252.7M | +30.9% |
| Total Assets | $266.2M | +34.0% |
| Current Liabilities | $14.2M | +48.2% |
| Total Liabilities | $21.0M | +71.7% |
| Stockholders' Equity | $245.2M | +31.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$70.8M | -16.0% |
| Capital Expenditures | $845K | +11.9% |
| Investing Cash Flow | -$45.5M | +44.1% |
| Financing Cash Flow | $131.2M | -7.3% |
| Free Cash Flow | -$71.6M | -15.9% |